Results
|
|
1.
|
|
|
|
2.
|
|
|
|
3.
|
|
|
|
4.
|
|
|
|
5.
|
|
|
|
6.
|
|
|
|
7.
|
|
|
|
8.
|
|
|
|
9.
|
|
|
|
10.
|
Risk of non-AIDS-defining events among HIV-infected patients not yet on antiretroviral therapy. [electronic resource] by
- Zhang, S
- van Sighem, A
- Kesselring, A
- Gras, L
- Prins, J M
- Hassink, E
- Kauffmann, R
- Richter, C
- de Wolf, F
- Reiss, P
Producer: 20150825
In:
HIV medicine vol. 16
Availability: No items available.
|
|
|
11.
|
Pharmacokinetics of stavudine and didanosine coadministered with nelfinavir in human immunodeficiency virus-exposed neonates. [electronic resource] by
- Rongkavilit, C
- Thaithumyanon, P
- Chuenyam, T
- Damle, B D
- Limpongsanurak, S
- Boonrod, C
- Srigritsanapol, A
- Hassink, E A
- Hoetelmans, R M
- Cooper, D A
- Lange, J M
- Ruxrungtham, K
- Phanuphak, P
Producer: 20020204
In:
Antimicrobial agents and chemotherapy vol. 45
Availability: No items available.
|
|
|
12.
|
HCV-specific T-cell responses in injecting drug users: evidence for previous exposure to HCV and a role for CD4+ T cells focussing on nonstructural proteins in viral clearance. [electronic resource] by
- Ruys, T A
- Nanlohy, N M
- van den Berg, C H S B
- Hassink, E
- Beld, M
- van de Laar, T
- Bruisten, S
- Wit, F
- Krol, A
- Prins, M
- Lange, J
- van Baarle, D
Producer: 20080603
In:
Journal of viral hepatitis vol. 15
Availability: No items available.
|
|
|
13.
|
Comparison of two once-daily regimens with a regimen consisting of nelfinavir, didanosine, and stavudine in antiretroviral therapy-naïve adults: 48-week results from the Antiretroviral Regimen Evaluation Study (ARES). [electronic resource] by
- Lowe, S H
- Wensing, A M J
- Hassink, E A M
- ten Kate, R W
- Richter, C
- Schreij, G
- Koopmans, P P
- Juttmann, J R
- van der Tweel, I
- Lange, J M A
- Borleffs, J C C
Producer: 20060821
In:
HIV clinical trials vol. 6
Availability: No items available.
|
|
|
14.
|
Comparison of first-line antiretroviral therapy with regimens including nevirapine, efavirenz, or both drugs, plus stavudine and lamivudine: a randomised open-label trial, the 2NN Study. [electronic resource] by
- van Leth, F
- Phanuphak, P
- Ruxrungtham, K
- Baraldi, E
- Miller, S
- Gazzard, B
- Cahn, P
- Lalloo, U G
- van der Westhuizen, I P
- Malan, D R
- Johnson, M A
- Santos, B R
- Mulcahy, F
- Wood, R
- Levi, G C
- Reboredo, G
- Squires, K
- Cassetti, I
- Petit, D
- Raffi, F
- Katlama, C
- Murphy, R L
- Horban, A
- Dam, J P
- Hassink, E
- van Leeuwen, R
- Robinson, P
- Wit, F W
- Lange, J M A
Producer: 20040510
In:
Lancet (London, England) vol. 363
Availability: No items available.
|